STOCK TITAN

Deanna Strable‑Soethout (PFG) files Form 144: 30,708 shares to be sold

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Deanna Strable‑Soethout reports proposed sale of 30,708 shares of Common Stock on 06/12/2026. The sale is described as an exercise of stock options with cash consideration.

The filing also records prior 10b5-1 transactions: 19,767 shares sold on 06/11/2026 for $2,175,556.02. The notice lists Morgan Stanley Smith Barney LLC as broker/dealer information.

Positive

  • None.

Negative

  • None.

Insights

Form 144 lists a proposed sale tied to option exercise and a recent 10b5-1 sale.

The filing shows a proposed disposition of 30,708 shares on 06/12/2026

Separately, a prearranged 10b5-1 sale of 19,767 shares closed on 06/11/2026 for $2,175,556.02. Confirmation of trade settlement and broker routing is the primary compliance checkpoint.

Proposed shares to sell 30,708 shares proposed sale on <date>06/12/2026</date>
10b5-1 shares sold 19,767 shares sale on <date>06/11/2026</date>
Proceeds from 10b5-1 sale $2,175,556.02 proceeds for 19,767 shares on <date>06/11/2026</date>
Form 144 regulatory
"144: Filer Information | 144: Issuer Information | 144: Securities To Be Sold"
Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.
10b5-1 regulatory
"10b5-1 Sales for DEANNA STRABLE-SOETHOUT 711 High Street Des Moines IA 50392"
A 10b5-1 plan is a pre-set schedule that lets company insiders buy or sell shares according to written instructions made when they do not possess material, nonpublic information. Think of it as a timed automatic payment for stock trades: it helps insiders avoid accusations of trading on secret information and gives outside investors a clearer signal about whether sales are routine or potentially informative about the company’s prospects.
exercise of stock options financial
"Common | 06/12/2026 | Exercise of Stock Options | Issuer"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the PFG Form 144 report?

The Form 144 reports a proposed sale of 30,708 shares of common stock on 06/12/2026, described as resulting from an exercise of stock options. It also records a prior 10b5-1 sale of 19,767 shares on 06/11/2026.

Who executed the 10b5-1 sale reported in the filing for PFG?

Deanna Strable‑Soethout is named in the filing; the excerpt shows a 10b5-1 sale of 19,767 shares on 06/11/2026 with proceeds of $2,175,556.02. Broker information lists Morgan Stanley Smith Barney LLC.

What is the stated mechanism for the 30,708-share transaction in PFG's filing?

The filing describes the 30,708-share transaction on 06/12/2026 as occurring in connection with an exercise of stock options and lists cash as the consideration method for that exercise.

Does the filing state who will receive proceeds from the sales?

The excerpt lists transaction details and broker information but does not specify the recipient party for proceeds beyond indicating the sale method and broker. Cash-flow treatment beyond the exercise description is not detailed in the provided text.